NIH research findings: Women given dilantin during pregnancy may have children who develop neuroblastoma.
D002648:Child; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects*; D008431:Maternal-Fetal Exchange; D009447:Neuroblastoma / Q000139:chemically induced*; D011247:Pregnancy
D006827:Hydantoins